A phase 2 trial finds that for patients with HER2+ metastatic colorectal cancer, dual HER2-inhibitor therapy can be a similarly efficacious but less toxic alternative to EGFR inhibitor therapy.
Current optical and electron microscopy imaging techniques are not suited for measuring the dynamic characteristics of living microorganisms at tiny scales due to complex sample preparation methods or ...
Is Bitcoin Bottom In? BTC's Price Action is Inverse of December Peak Above $108K BTC's latest price action seems to contrast sharply with the uptrend exhaustion observed at record highs above $ ...